Результаты поиска

Protocol for the TMaC Study: A Patient-Blinded, Randomised, Sham-Controlled, Parallel-Group Study Evaluating Effects of Repetitive Transcranial Magnetic Stimulation on Chronic Chemotherapy-Induced Pain in Bowel Cancer Patients.

IntroductionChemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating consequence for people undergoing treatment for cancer, especially bowel cancer. Painful CIPN contributes to psychological distress, functional decline and reduced quality of life. Additionally, it is a dose-limiting factor for anticancer agents, compromising chemotherapy effectiveness and patient survival. To date, no effective long-term management options exist for painful CIPN. Whilst evidence suggests analgesic effects of repetitive transcranial magnetic stimulation (rTMS), little is known regarding

Summarizing Consensus Guidelines on Obesity Management: A Joint, Multidisciplinary Venture of the International Federation for the Surgery of Obesity & Metabolic Disorders (IFSO) and World Gastroenterology Organisation (WGO).

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023.

With 54 new drugs and seven cellular and gene therapy products, the approvals by the US Food and Drug Administration (FDA) recovered 2023 from the 2022 dent back to the levels of 2020-2021. As in previous years of this annual review, we assign these new drugs to one of three levels of innovation: first drug against a condition ("first-in-indication"), first drug using a novel molecular mechanism ("first-in-class"), and "next-in-class," i.e., a drug using an already exploited molecular mechanism. We identify four (7%) "first-in-indication," 22 (36%) "first-in-class," and 35 (57%) "next-in-class

High-Dose Vitamin C in Advanced-Stage Cancer Patients.

High-dose intravenously administered vitamin C (IVC) is widely used in cancer patients by complementary and alternative medicine practitioners. The most frequent indications for IVC therapy result from the belief in its effectiveness as a potent anti-cancer agent which additionally enhances chemosensitivity of cancer cells and reduces chemotherapy-related toxicities and fatigue intensity. In this narrative review, we decided to deal with this issue, trying to answer the question whether there is any scientific evidence supporting the rationale for application of high-dose IVC therapy in advanc

Acute interstitial nephritis - a reappraisal and update.

Acute interstitial nephritis (AIN) is an under recognized and under diagnosed cause of acute kidney injury (AKI). It is estimated to account for 15 - 20% of cases of AKI; it is the reported diagnosis in 2.8% of all kidney biopsies, and 13.5% of biopsies done specifically for acute renal failure. Considerable evidence implicates antigen initiated cell-mediated injury in the pathogenesis of AIN. Drugs account for 70% of all cases, with over 150 different agents incriminated. The remaining cases are due to infections, autoimmune diseases, and rarely idiopathic. The central component of renal inju

Peripheral Neuropathy under Oncologic Therapies: A Literature Review on Pathogenetic Mechanisms.

Peripheral neurologic complications are frequent adverse events during oncologic treatments and often lead to dose reduction, administration delays with time elongation of the therapeutic plan and, not least, worsening of patients' quality of life. Experience skills are required to recognize symptoms and clinical evidences and the collaboration between different health professionals, in particular oncologists and hospital pharmacists, grants a correct management of this undesirable occurrence. Some classes of drugs (platinates, vinca alkaloids, taxanes) typically develop this kind of side effe

Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations.

Inflammatory bowel disease (IBD) management traditionally focuses on intestinal inflammation, yet extraintestinal manifestations can substantially impair patient quality of life. In this perspective, we emphasize the broad systemic impact of IBD-from highly prevalent conditions such as anemia, metabolic dysfunction-associated steatotic liver disease, or fatigue to rare but severe complications like interstitial lung disease and drug-induced glomerulonephritis. We review underlying mechanisms linking gut inflammation to distant organs, including immune dysregulation, microbial translocation, an

Osseous Sarcoidosis Mimicking Metastatic Disease in a Patient With Longstanding Pulmonary Sarcoidosis: A Case Report.

Sarcoidosis is a multisystem granulomatous disease in which osseous involvement is uncommon and most often affects the small bones of the hands and feet, whereas axial skeletal disease remains underrecognized and may mimic metastatic malignancy. A 72-year-old man with longstanding pulmonary sarcoidosis and moderate persistent asthma was incidentally found to have multifocal sacral and iliac bone lesions on lumbar spine magnetic resonance imaging (MRI) obtained for evaluation of back pain and radiculopathy. These lesions were radiologically suspicious for osseous metastases, prompting systemic

Krill oil extract suppresses the proliferation of colorectal cancer cells through activation of caspase 3/9.

BackgroundCurrently available treatments for colorectal cancer (CRC) associate with numerous side-effects that reduce patients' quality of life. The effective nutraceuticals with high anti-proliferative efficacy and low side-effects are desirable. Our previous study has reported that free fatty acids extract (FFAE) of krill oil induced apoptosis of CRC cells, possibly associated with changes in mitochondrial membrane potential (MMP). The aims of this study were to compare the anti-proliferative efficacy of FFAE from krill oil on CRC cells with commonly used chemotherapeutic drug, Oxaliplatin,

The therapeutic effect of modified Huangqi Guizhi Wuwu Tang for multiple myeloma: An 18-year follow-up case report.

RationaleMultiple myeloma (MM) is a hematologic malignancy characterized by proliferation of clonal plasma cells in the bone marrow. The median survival has increased to 6 years in recent years. But MM remains incurable. Some studies about the effects of Chinese herb medicine on MM have been carried out. Long survival in MM patients through Traditional Chinese Medicine (TCM) therapies has been reported rarely before.Patient concernsWe report a case of a female patient who was diagnosed with MM in 2000 at the age of 49. She received 9 cycles of multiple chemotherapeutic regimens mainly based on

Profile of elderly patients receiving antiretroviral therapy at Newlands Clinic in 2020: A cross-sectional study.

BACKGROUND: People living with HIV (PLWH) face new challenges such as accelerated ageing and higher rates of comorbidities including cardiovascular, renal and metabolic diseases as they age. OBJECTIVES: To profile the demographic and clinical characteristics of elderly patients receiving HIV care at Newlands Clinic (NC), Harare, Zimbabwe, as of 01 October 2019. METHODS: A cross-sectional analysis was conducted using clinic data. All patients who were 50 years and older on 01 October 2019 were enrolled. Descriptive statistics (medians, interquartile ranges [IQRs] and proportions) were used to

2021 Scientific Session of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), Las Vegas, Nevada, 31 August–3 September 2021: Video Loops

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Unleashing the Impact of Exosomes Derived from Human Placental Mesenchymal Stem Cells (hPMSCs) on U-266 Myeloma Cell Line.

Multiple myeloma (MM) is a malignancy of plasma cells, terminally differentiated B cells, with complications like hypercalcemia, renal failure, anemia, and bone disease, which are also known as CRAB criteria. MM develops from monoclonal gammopathy of unknown significance (MGUS), a pre-malignant plasma cell dyscrasia. Over some time, MGUS has the potential to progress into smoldering multiple myeloma (SMM), which can evolve into MM. MM rarely progresses into plasma cell leukemia (PCL), a condition in which malignant plasma cells no longer stay in the bone marrow niche and circulate in the perip

Совпадение в полном тексте источника
… The Alizarin staining depicted the presence of calcium oxalates on the differentiated hPMSCs to osteoblasts, and intracellular lipid droplets staining using oil red- O proved the adipogenesis of hPMSCs. These observations were absent in the undifferentiated hPMSCs groups. …

Diagnosis, treatment, and follow-up of patients with hypophosphatasia.

INTRODUCTION: Hypophosphatasia is a rare inherited systemic metabolic disorder, with an estimated prevalence in the severe forms of the disease of 1/100.000-1/300.000, that affects the typical architecture of bone, leading to defective mineralization during growth and remodeling. It is characterized by loss-of-function variants in the ALPL gene, resulting in low activity of tissue-nonspecific alkaline phosphatase. In severe cases, it can be fatal. OBJECTIVE: To generate recommendations on the diagnosis, treatment, and follow-up of patients with hypophosphatasia based on available evidence. M

Совпадение в полном тексте источника
… myeloma Diet related Milk-alkali syndrome Starvation Vitamin C deficency Vitamin D intoxication Zinc or magnesium deficency Others Wilson disease Cardiac bypass surgery Celiac disease Hemochromatosis Radioactive heavy metal intoxication Use of inappropriate reference ranges Inadequate blood collection (Oxalates … related Milk-alkali syndrome | Starvation Vitamin C deficency | Vitamin D intoxication Zinc or magnesium deficency | Others Wilson disease | Cardiac bypass surgery Celiac disease | Hemochromatosis Radioactive heavy metal intoxication | Use of inappropriate reference ranges Inadequate blood collection (Oxalates …

Р

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

CD70-targeted platform for diagnosing and treating multiple myeloma.

BackgroundCD70, overexpressed in multiple myeloma (MM), is a promising target for theranostics. This study developed a CD70-targeted theranostic pair: the immuno-positron emission tomography tracer [89Zr]Zr-DFO-ABDB6 and the therapeutic agent [177Lu]Lu-DOTA-ABDB6, aiming to combine imaging and radiotherapy for MM.MethodsCD70 expression was confirmed in patients with MM samples (positivity rate, 66.7%) and RPMI-8226 xenografts. The nanobody derivative ABDB6 was conjugated to DFO or DOTA and radiolabeled with 89Zr or 177Lu. Pharmacokinetics, biodistribution, and toxicity were evaluated in NCG an

Сипонимод поддерживает воспоминание в неподдерживающей среде.

Воспаление, характерное для множественных повреждений склероза (MS), приводит к функциональным повреждениям и постепенной потере аксона с течением времени. Хотя, как считается, ремилеляция защищает аксоны, внутренние регенерационные процессы часто являются неполными или полностью неэффективными у многих пациентов с синдромом MS. Хотя точные причины провала воспоминаний остаются неясными, неоднократное обезвоживание в ранее затронутых районах с белыми телами является признанным фактором, способствующим этому. В одном из предыдущих исследований мы продемонстрировали, что модификатор Siпонimod с

Alpha-mangostin Amliorates Apoptosis, воспаление и окисляющий стресс в результате разложения Cuprizon в C57BL/6 Мыши.

ВВЕДЕНИЕ: Согласно сообщениям, альфа-мангостин (α-MG), самый изобилийный ксантон, найденный в Гарцинии Мангостана Линн, обладает мощными антиоксидантами и антивоспламеняющимися свойствами. Цель этого исследования заключалась в изучении нейрозащитного воздействия α-MG на вызванную кубической зоной (CZ) демиелинизацию в корпусе каллосум (CC) мышей, ставшей установившейся моделью животных для множественного склероза (MS). МЕТОДЫ: Взрослая женщина C57BL/6 Мыши были накормлены чау, в котором содержится 0.4% (w/w) CZ для 5 недель. Животные были произвольно назначены six группы: (1) контрольная групп

POSTER PRESENTATIONS

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Микробиота и почки в Камеруне работают в автосомных доминирующих полициклических болезнях почек: перекрестное исследование.

Гут дисбиоз патобионтов (Enterobacter, Eschericia и Salmonella) и симбионтов (Bifidobacterium, Lactobacillus и Prevotella) может происходить во время развития хронической болезни почек (CKD). Мы провели оценку связей между репрезентативными симбионтами (Bifidobacterium и Lactobacillus) и патобионтами (Enterobacteriaceae) с функцией почек у лиц с автосомальным доминирующим полициклическим заболеванием почек (ADPKD). МЕТОДЫ: В этом перекрестном исследовании 29 Пациенты ADPKD сравнивались с пациентами 15 контроля в районе действия 2::1 соотношение. Были собраны клинические данные и биологические